These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38431221)

  • 1. Somatic Loss-of-Function PIK3R1 and Activating Non-hotspot PIK3CA Mutations Associated with Capillary Malformation with Dilated Veins (CMDV).
    De Bortoli M; Queisser A; Pham VC; Dompmartin A; Helaers R; Boutry S; Claus C; De Roo AK; Hammer F; Brouillard P; Abdelilah-Seyfried S; Boon LM; Vikkula M
    J Invest Dermatol; 2024 Sep; 144(9):2066-2077.e6. PubMed ID: 38431221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth.
    Cottrell CE; Bender NR; Zimmermann MT; Heusel JW; Corliss M; Evenson MJ; Magrini V; Corsmeier DJ; Avenarius M; Dudley JN; Johnston JJ; Lindhurst MJ; Vigh-Conrad K; Davies OMT; Coughlin CC; Frieden IJ; Tollefson M; Zaenglein AL; Ciliberto H; Tosi LL; Semple RK; Biesecker LG; Drolet BA
    Genet Med; 2021 Oct; 23(10):1882-1888. PubMed ID: 34040190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population : List the full names and institutional addresses for all authors.
    Sasaki Y; Ishikawa K; Hatanaka KC; Oyamada Y; Sakuhara Y; Shimizu T; Saito T; Murao N; Onodera T; Miura T; Maeda T; Funayama E; Hatanaka Y; Yamamoto Y; Sasaki S
    Orphanet J Rare Dis; 2023 Sep; 18(1):270. PubMed ID: 37667289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation.
    Le Cras TD; Goines J; Lakes N; Pastura P; Hammill AM; Adams DM; Boscolo E
    Angiogenesis; 2020 Aug; 23(3):425-442. PubMed ID: 32350708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Activating PIK3CA Mutations Cause Venous Malformation.
    Limaye N; Kangas J; Mendola A; Godfraind C; Schlögel MJ; Helaers R; Eklund L; Boon LM; Vikkula M
    Am J Hum Genet; 2015 Dec; 97(6):914-21. PubMed ID: 26637981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PIK3CA mutation in an acquired capillary malformation.
    Rosenthal J; Sibbald C; Jen M; Deardorff MA; Treat J
    Pediatr Dermatol; 2020 Jan; 37(1):246-247. PubMed ID: 31830321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations.
    Couto JA; Huang L; Vivero MP; Kamitaki N; Maclellan RA; Mulliken JB; Bischoff J; Warman ML; Greene AK
    Plast Reconstr Surg; 2016 Jan; 137(1):77e-82e. PubMed ID: 26368330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
    Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
    Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants.
    De Bortoli M; Ivars M; Revencu N; Nassogne MC; Lavarino C; Paco S; Lammens M; Renders A; Dumitriu D; Helaers R; Boon LM; Baselga E; Vikkula M
    Am J Med Genet A; 2024 Jun; 194(6):e63551. PubMed ID: 38321651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants.
    Goss JA; Konczyk DJ; Smits P; Sudduth CL; Bischoff J; Liang MG; Greene AK
    Clin Genet; 2020 May; 97(5):736-740. PubMed ID: 31909475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy.
    Tharin Z; Richard C; Derangère V; Ilie A; Arnould L; Ghiringhelli F; Boidot R; Ladoire S
    Sci Rep; 2023 Mar; 13(1):4467. PubMed ID: 36934165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of vascular birthmarks.
    Mahajan P; Bergstrom KL; Phung TL; Metry DW
    Clin Dermatol; 2022; 40(4):313-321. PubMed ID: 35181412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
    Urick ME; Rudd ML; Godwin AK; Sgroi D; Merino M; Bell DW
    Cancer Res; 2011 Jun; 71(12):4061-7. PubMed ID: 21478295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth.
    Couto JA; Ayturk UM; Konczyk DJ; Goss JA; Huang AY; Hann S; Reeve JL; Liang MG; Bischoff J; Warman ML; Greene AK
    Angiogenesis; 2017 Aug; 20(3):303-306. PubMed ID: 28120216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.
    di Blasio L; Puliafito A; Gagliardi PA; Comunanza V; Somale D; Chiaverina G; Bussolino F; Primo L
    Cell Death Dis; 2018 Jan; 9(2):45. PubMed ID: 29352118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
    Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
    Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CA.
    Davis S; Ware MA; Zeiger J; Deardorff MA; Grand K; Grimberg A; Hsu S; Kelsey M; Majidi S; Matthew RP; Napier M; Nokoff N; Prasad C; Riggs AC; McKinnon ML; Mirzaa G
    Am J Med Genet A; 2020 Jan; 182(1):162-168. PubMed ID: 31729162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway.
    Turturro SB; Najor MS; Yung T; Portt L; Malarkey CS; Abukhdeir AM; Cobleigh MA
    Breast Cancer Res Treat; 2019 Sep; 177(2):325-333. PubMed ID: 31209687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.
    Cobleigh MA; Layng KV; Mauer E; Mahon B; Hockenberry AJ; Abukhdeir AM
    Breast Cancer Res Treat; 2024 Apr; 204(2):407-414. PubMed ID: 38153569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.